Susannah Gray is a director of Maravai LifeSciences Holdings Inc - Ordinary Shares.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
MARAVAI LIFESCIENCES HOLDINGS, INC.
19 Jul 23
4
Morphic Holding, Inc.
2 Jun 23
4
4D Molecular Therapeutics, Inc.
25 May 23
4
Theravance Biopharma, Inc.
4 May 23
4
Theravance Biopharma, Inc.
28 Feb 23
3
Theravance Biopharma, Inc.
28 Feb 23
4
Morphic Holding, Inc.
10 Jun 22
4
4D Molecular Therapeutics, Inc.
25 May 22
4/A
Morphic Holding, Inc.
29 Apr 22
4/A
Morphic Holding, Inc.
29 Apr 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jul 23 | MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 24,000 | 0.00 | 60,123 |
1 Jun 23 | MORF Morphic Holding | Director Stock Option Common Stock | Grant | Acquire A | No | No | 56.47 | 12,535 | 707.85 k | 12,535 |
23 May 23 | FDMT 4D Molecular Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 17.98 | 22,500 | 404.55 k | 22,500 |
2 May 23 | TBPH Theravance Biopharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 9,132 | 0.00 | 20,951 |
2 May 23 | TBPH Theravance Biopharma | Share Option Ordinary Shares | Grant | Acquire A | No | No | 10.95 | 22,044 | 241.38 k | 22,044 |